Embraer announces the Phenom 300MED, a unique Medevac solution for the best-selling light jet in the market

Embraer announced the Phenom 300MED, a unique Medevac solution for Phenom 300 series aircraft, which is also available for retrofit, through a partnership with umlaut and Aerolite. Embraer and umlaut are jointly developing and certifying a new supplemental type certificate (STC) utilizing Aerolite equipment.

The Phenom 300MED, which is now available for customer configuration, is representative of Embraer’s modern and versatile product portfolio and the company’s intent to deliver the ultimate experience in business aviation, now including the Medevac segment. Designed as an ideal solution for both civil and government applications, the Medevac solution will be installed exclusively by Embraer’s award-winning Services & Support organization, ensuring the highest quality, reliability, and service experience, direct from the manufacturer.

 “The Phenom 300 platform ? the most successful light jet in the world ? with its unparalleled technology, comfort, and performance, is uniquely positioned for Medevac operations,” said Michael Amalfitano, President & CEO, Embraer Executive Jets. “Given the current health crisis, we are proud to be working with two world-class Medevac-solutions partners, and we are primed to immediately start taking orders for this unprecedented air ambulance solution.”

 “umlaut is known for generating full service, cross-industry, and end-to-end solutions. Now, we are combining Embraer and umlaut’s strong competencies in aircraft engineering, refurbishment, and certification know-how to bring an unprecedented solution to the market. Together with Aerolite’s state-of-the-art aeromedical equipment, we will deliver a solution that will transcend the current market. Designed from the ground up, this new solution will offer a hospital-grade interior with the flexibility for configuration and reconfiguration that simply isn’t available today,” said Tobias Geißinger, Managing Director of umlaut.